Basic Science of Immunology - Adaptive Immunity
Hanane Touil, PhD
Post-Doctoral Scientist
Columbia University
New York, New York, United States
Masashi Fujita, PhD
Senior Associate Research Scientist
Columbia University
New York, New York, United States
Alexandra Kroshilina, B.Sc.
Technician
Columbia University
New york, New York, United States
Christina Yung, B.Sc.
Lab manager
Columbia University
New York, New York, United States
Joshua Gray, PhD
Post-Doctoral Scientist
COlumbia university
New York, New York, United States
Leah Zuroff, MD, MS
Neurology resident
The university of pennsylvania
Philadelphia, Pennsylvania, United States
Adam M. Brickman, PhD
Professor of Neuropsychology in Neurology
Columbia Unversity
New york, New York, United States
Jennifer J. Manly, PhD
Professor in Neuropsychology in Neurology
Columbia university
New york, New York, United States
Donna L. Farber, pHd
george H. Humphreys, II Professor of Surgical Sciences (in Surgery), Chief, Division of Surgical Sci
coLUMBIA uNIVERSITY
New York, New York, United States
Amit Bar-or, MD, FRCP
Melissa and Paul Anderson President's Distinguished Professor Chief, Multiple Sclerosis Division
The University of Pennsylvania
Philadelphia, Pennsylvania, United States
Yaakov Stern, PhD
Florence Irving Professor of Neuropsychology in the Departments of Neurology
Columbia University
New York, New York, United States
Philip L. De Jager, MD. PhD
Weil-Granat Professor of Neurology
Columbia university
New York, New York, United States
Immunosenescence (ISC) is the natural aging of the immune system, involving gradual changes in immune-cell proportions and functions. Genetic variation, sexual-dimorphism and previous viral infections may influence it. Thus far, limited large-scale studies are available, mostly involving European descends, although clear multi-modal ISC-trajectories remain unknown. To characterize ISC phenotypic/functional changes in a large-scale manner, we used PBMC samples (n=257, age: 18-84 years) part of two Columbia aging-cohorts.
Multiparametric-cytometry profiles, single-cell-RNA-sequencing, bulk-PBMC RNA-sequencing and T-cell proliferation were captured. First, we used standard FlowJo bi-dimensional gating to analyze cell-proportions and MFI of main innate and adaptive immune-cells, plus other markers: CD11c, CD57, PD-1/PD-1L & KLRG-1. Second, we processed .fcs files to create a multidimensional data matrix analyzed using PhenoGraph algorithm to empirically cluster PBMCs into 20 discrete cell-subtypes.
Preliminary analyses of a cohort representative (n=60), confirms previous findings: decrease in naïve CD8 T-cells (p=0.000054), increase of CD8 TEMRA T-cells (p=0.0027), and decrease of CD20+B-cells (p=0.0028), while CD11c+CD20+ B-cells increased with advancing age. No meaningful age-associated changes were noted in IgD+naïve, nor IgD-/+CD27+memory B-cells. We further found a population of CD56+CD8+NKT-cells increasing with age (p=0.0019). Next, our clustering analysis uncovered an unexpected subset of CD56+PD-L1+NK-cells increasing with age (p=0.000096).
We report several aging-related cell populations including well-known ones. ISC signatures included NKT-cells and CD11c+B-cells. Surprisingly, we identified an intriguing senescent PD-1L+NK population, perhaps contributing to higher cancer incidence in elderly. Results from n=257 will be presented, enabling ISC-trajectories assessment amongst African-American, Latin-x, and non-Hispanic Whites in an ongoing effort to establish personalized ISC-trajectories.